Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference
Bio-Rad Laboratories (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, has announced its participation in the UBS Global Healthcare Conference. CEO Norman Schwartz and CFO Roop K. Lakkaraju will engage in a fireside chat on Wednesday, November 13, 2024, at 1:15 PM Pacific Time. The event will be accessible via live webcast and replay through the Investor Relations section of Bio-Rad's website.
Bio-Rad Laboratories (NYSE: BIO e BIO.B), un leader globale nei prodotti per la ricerca nelle scienze della vita e nei diagnosi clinici, ha annunciato la sua partecipazione alla UBS Global Healthcare Conference. L'amministratore delegato Norman Schwartz e il direttore finanziario Roop K. Lakkaraju parteciperanno a una conversazione informale mercoledì 13 novembre 2024, alle 1:15 PM ora del Pacifico. L'evento sarà accessibile tramite webcast dal vivo e in replica nella sezione Relazioni con gli Investitori del sito web di Bio-Rad.
Bio-Rad Laboratories (NYSE: BIO y BIO.B), un líder global en productos de investigación en ciencias de la vida y diagnósticos clínicos, ha anunciado su participación en la UBS Global Healthcare Conference. El CEO Norman Schwartz y el CFO Roop K. Lakkaraju participarán en una charla informal el miércoles 13 de noviembre de 2024 a la 1:15 PM hora del Pacífico. El evento será accesible a través de una transmisión web en vivo y una repetición en la sección de Relaciones con Inversores del sitio web de Bio-Rad.
Bio-Rad Laboratories (NYSE: BIO 및 BIO.B)는 생명과학 연구 및 임상 진단 제품의 글로벌 리더로서 UBS 글로벌 헬스케어 컨퍼런스에 참여할 것이라고 발표했습니다. CEO 노먼 슈워츠와 CFO 루프 K. 락카라주는 2024년 11월 13일 수요일 오후 1시 15분(태평양 표준시)에 잔디옆 대화에 참여할 예정입니다. 이 행사는 Bio-Rad 웹사이트의 투자자 관계 섹션을 통해 실시간 웹캐스트 및 재방송으로 접근할 수 있습니다.
Bio-Rad Laboratories (NYSE: BIO et BIO.B), un leader mondial dans les produits de recherche en sciences de la vie et de diagnostics cliniques, a annoncé sa participation à la UBS Global Healthcare Conference. Le PDG Norman Schwartz et le Directeur Financier Roop K. Lakkaraju participeront à une discussion informelle le mercredi 13 novembre 2024 à 13h15 heure du Pacifique. L'événement sera accessible via un webinaire en direct et une rediffusion dans la section Relations avec les investisseurs du site Web de Bio-Rad.
Bio-Rad Laboratories (NYSE: BIO und BIO.B), ein globaler Marktführer in der Forschung im Bereich der Lebenswissenschaften und klinischer Diagnostikprodukte, hat seine Teilnahme an der UBS Global Healthcare Conference angekündigt. CEO Norman Schwartz und CFO Roop K. Lakkaraju werden am Mittwoch, den 13. November 2024, um 13:15 Uhr Pazifischer Zeit in einem informellen Gespräch teilnehmen. Die Veranstaltung wird über einen Live-Webcast und eine Wiederholung über den Bereich Investor Relations auf der Website von Bio-Rad zugänglich sein.
- None.
- None.
A live webcast and subsequent replay of the event will be available in the Investor Relations section of Bio-Rad’s website at bio-rad.com.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241031858468/en/
Investor Contact:
Edward Chung, Investor Relations
510-741-6104
ir@bio-rad.com
Media Contact:
Anna Gralinska, Corporate Communications
510-741-6643
cc@bio-rad.com
Source: Bio-Rad Laboratories, Inc.
FAQ
When is Bio-Rad's (BIO) fireside chat at the UBS Global Healthcare Conference 2024?
How can investors watch Bio-Rad's (BIO) UBS Conference presentation?
Which Bio-Rad (BIO) executives are participating in the UBS Healthcare Conference 2024?
What type of event is Bio-Rad (BIO) participating in at the UBS Global Healthcare Conference?
